Long-Acting Injectable HIV Treatment - 2 presentations (Group 6)

State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIVПодробнее

Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCPПодробнее

6 Practical Steps to Integrating Long-Acting Injectables for HIV Prevention and TreatmentПодробнее

Novel Treatments for HIV Currently in DevelopmentПодробнее

Long Acting Injectable Antiretroviral Therapy to Improve Adherence to HIV TreatmentПодробнее

Preparing for Pharmacy-based Delivery of Long-Acting Injectable HIV AntiretroviralsПодробнее

Long-acting Injectable HIV Treatment Implementation and Coordination (20674)Подробнее

New Long-Acting Injectable HIV DrugПодробнее

Long-Acting Injectable PrEP and HIV Treatment MicrolearningПодробнее

Operationalizing Use of Long-Acting Injectable ARTПодробнее

New HIV prevention option, WHO releases long-acting guidelinesПодробнее

RWCC2020 - Promises and Challenges of Long-Acting Injectable Formulations by Constance A. Benson, MDПодробнее

Long-Acting Injectables to Treat HIVПодробнее

What do Long-Acting Injectables Offer Patients With HIV?Подробнее

Long-Acting HIV Drugs for Treatment: Data and Potential Implementation - Charles FlexnerПодробнее

Adolescents and Young Adults with HIV Using Long-Acting Injectable (...) - Tierra WilliamsПодробнее

HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City (20444)Подробнее

Long-Acting Injectable: An Exciting New Option for HIV PreventionПодробнее

Day 2 at IAS 2023 REPRIEVE Study and Long-Acting Treatment & Prevention OptionsПодробнее